Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.54 USD | +2.36% | +16.53% | -3.46% |
16/07 | Transcript : Arrowhead Pharmaceuticals, Inc. - Special Call | |
05/07 | HC Wainwright Cuts Price Target on Arrowhead Pharmaceuticals to $60 From $90, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.46% | 358.44Cr | |
+20.17% | 13TCr | |
+24.67% | 12TCr | |
+25.44% | 2.77TCr | |
-17.74% | 2.03TCr | |
-15.17% | 1.68TCr | |
-15.21% | 1.56TCr | |
+11.91% | 1.48TCr | |
-47.10% | 1.46TCr | |
+54.50% | 1.44TCr |
- Stock Market
- Equities
- ARWR Stock
- News Arrowhead Pharmaceuticals, Inc.
- Morgan Stanley Raises Price Target on Arrowhead Pharmaceuticals to $40 From $37, Maintains Equalweight Rating